BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37305571)

  • 1. A case report of surgical resection treatment for complete remission after chemotherapy for advanced pancreatic cancer.
    Zhang Z; Lin H; Li H; Wang X
    Front Oncol; 2023; 13():1155233. PubMed ID: 37305571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A successful case of locally advanced pancreatic cancer undergoing curative distal pancreatectomy with en bloc celiac axis resection after combination chemotherapy of nab-paclitaxel with gemcitabine.
    Hiyoshi M; Nanashima A; Wada T; Tsuchimochi Y; Hamada T; Yano K; Imamura N; Fujii Y
    Clin J Gastroenterol; 2017 Dec; 10(6):551-557. PubMed ID: 29086227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
    Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V;
    Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A locally advanced pancreatic body cancer presenting common bile duct invasion resected via distal pancreatectomy after gemcitabine plus nab-paclitaxel chemotherapy: A case report.
    Kawasaki H; Hoshikawa M; Kyoden Y; Iijima T; Kojima H; Yamamoto J
    Int J Surg Case Rep; 2022 Mar; 92():106818. PubMed ID: 35158234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conversion Surgery for Initially Unresectable Locally Advanced Pancreatic Cancer Following Gemcitabine plus Nab-Paclitaxel - A Case Report].
    Nakamoto S; Nishiyama R; Kaneda T; Yokota M; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Yamauchi H; Okuwaki K; Iwai T; Imaizumi H; Suzuki E; Hara A; Ichinoe M; Kida M; Watanabe M
    Gan To Kagaku Ryoho; 2017 Feb; 44(2):173-176. PubMed ID: 28223678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locally advanced pancreatic cancer successfully treated by distal pancreatectomy with celiac axis resection (DP-CAR) after S-1 with radiation therapy followed by gemcitabine/nab-paclitaxel therapy: a case report.
    Ariake K; Motoi F; Mizuma M; Murakami K; Takadate T; Ohtsuka H; Fukase K; Masuda K; Hayashi H; Nakagawa K; Sakata N; Morikawa T; Maeda S; Naitoh T; Egawa S; Unno M
    Surg Case Rep; 2017 Dec; 3(1):15. PubMed ID: 28101795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful conversion surgery of distal pancreatectomy with celiac axis resection (DP-CAR) with double arterial reconstruction using saphenous vein grafting for locally advanced pancreatic cancer: a case report.
    Murase Y; Ban D; Maekawa A; Watanabe S; Ishikawa Y; Akahoshi K; Ogawa K; Ono H; Kudo A; Kudo T; Tanaka S; Tanabe M
    Surg Case Rep; 2020 Dec; 6(1):302. PubMed ID: 33259017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study.
    Philip PA; Lacy J; Portales F; Sobrero A; Pazo-Cid R; Manzano Mozo JL; Kim EJ; Dowden S; Zakari A; Borg C; Terrebonne E; Rivera F; Sastre J; Bathini V; López-Trabada D; Asselah J; Saif MW; Shiansong Li J; Ong TJ; Nydam T; Hammel P
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):285-294. PubMed ID: 31953079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer.
    Petrioli R; Torre P; Pesola G; Paganini G; Paolelli L; Miano ST; Martellucci I; Francini G; Francini E
    J Geriatr Oncol; 2020 May; 11(4):647-651. PubMed ID: 31471168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer.
    Kunzmann V; Herrmann K; Bluemel C; Kapp M; Hartlapp I; Steger U
    Case Rep Oncol; 2014 Sep; 7(3):648-55. PubMed ID: 25408659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Boderline Resectable Pancreatic Cancer Curatively Resected after Chemotherapy with Gemcitabine and Nab-Paclitaxel].
    Kuwayama N; Natsume T; Kainuma O; Maruyama T; Tanaka H; Miyazaki A; Sato Y; Note H; Yoshioka T; Matsumoto Y; Suzuki K; Kato M; Oshima S; Ishigaki A; Mizumoto H; Shimizu S
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):721-724. PubMed ID: 31164515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of advanced pancreatic leiomyosarcoma treated with gemcitabine plus
    Kikuchi Y; Nishikawa Y; Amanuma M; Kishimoto Y; Takuma K; Wakayama M; Shibuya K; Okano N; Shimada H; Igarashi Y
    Int Cancer Conf J; 2021 Jan; 10(1):63-67. PubMed ID: 33489704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Modified Regimen of 21-day Nab-Paclitaxel Plus Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Real-World Study.
    Chang C; Meng L; Li X; Cheng K; Yi C; Peng B; Ma J; Cao D
    Cancer Control; 2022; 29():10732748221141233. PubMed ID: 36423238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous double primary malignancies of the pancreatic body and extrahepatic bile duct treated with pancreatoduodenectomy and splenic artery resection following neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel: a case report.
    Murokawa T; Okabayashi T; Sui K; Tabuchi M; Iwata J
    Surg Case Rep; 2022 Feb; 8(1):29. PubMed ID: 35171354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful conversion surgery for unresectable pancreatic cancer with peritoneal metastases after neoadjuvant albumin-bound paclitaxel and gemcitabine chemotherapy: case report and literature review.
    Kobayashi Y; Maeda S; Hama N; Miyamoto A; Uemura M; Miyake M; Nishikawa K; Hirao M; Kato T; Sekimoto M; Mori K; Mano M; Nakamori S
    Int Cancer Conf J; 2018 Jan; 7(1):20-25. PubMed ID: 31149507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of different neoadjuvant chemotherapy regimens with or without stereotactic body radiation therapy for borderline resectable pancreatic cancer: study protocol of a prospective, randomized phase II trial (BRPCNCC-1).
    Gao S; Zhu X; Shi X; Cao K; Bian Y; Jiang H; Wang K; Guo S; Zhang H; Jin G
    Radiat Oncol; 2019 Mar; 14(1):52. PubMed ID: 30917842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative treatment with gemcitabine plus nab-paclitaxel is a safe and effective chemotherapy for pancreatic adenocarcinoma.
    Ielpo B; Duran H; Diaz E; Fabra I; Caruso R; Ferri V; Malavé L; Hidalgo M; Alvarez R; Plaza C; Quijano Y; Vicente E
    Eur J Surg Oncol; 2016 Sep; 42(9):1394-400. PubMed ID: 26899943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinoma.
    Rogers JE; Mizrahi JD; Xiao L; Mohindroo C; Shroff RT; Wolff R; Varadhachary GR; Javle MM; Overman M; Fogelman DR; Raghav KPS; Pant S; McAllister F
    Cancer Med; 2020 Aug; 9(15):5406-5415. PubMed ID: 32519420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case of Initially Locally Advanced Pancreatic Cancer Curatively Resected after Carbon-Ion Radiotherapy with Gemcitabine].
    Miyazaki K; Hayashi H; Ishida M; Ohtsuka H; Mizuma M; Nakagawa K; Morikawa T; Motoi F; Kamei T; Shinoto M; Yamada S; Takiyama H; Unno M
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2266-2268. PubMed ID: 33468929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of successful conversion surgery for locally advanced pancreatic cancer with synchronous triple cancer of the lung and esophagus: a case report.
    Mita J; Iguchi T; Iseda N; Takada K; Hirose K; Miura N; Honboh T; Emi Y; Akashi T; Kato S; Sadanaga N; Matsuura H
    Surg Case Rep; 2022 Jan; 8(1):19. PubMed ID: 35067787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.